Literature DB >> 26392049

[Primum nil nocere].

C Roloff1.   

Abstract

Mesh：

Year:  2015        PMID： 26392049     DOI： 10.1007/s00120-015-3939-4

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  9 in total

1.  Sexual function with localized prostate cancer: active surveillance vs radical therapy.

Authors:  Roderick C N van den Bergh; Ida J Korfage; Monique J Roobol; Chris H Bangma; Harry J de Koning; Ewout W Steyerberg; Marie-Louise Essink-Bot
Journal:  BJU Int       Date:  2012-01-19       Impact factor: 5.588

2.  Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.

Authors:  Robert K Nam; Patrick Cheung; Sender Herschorn; Refik Saskin; Jiandong Su; Laurence H Klotz; Michelle Chang; Girish S Kulkarni; Yuna Lee; Ronald T Kodama; Steven A Narod
Journal:  Lancet Oncol       Date:  2014-01-17       Impact factor: 41.316

Review 3.  Active surveillance for clinically localized prostate cancer--a systematic review.

Authors:  Frederik B Thomsen; Klaus Brasso; Laurence H Klotz; M Andreas Røder; Kasper D Berg; Peter Iversen
Journal:  J Surg Oncol       Date:  2014-03-07       Impact factor: 3.454

Review 4.  Treatment options for prostate cancer: evaluating the evidence.

Authors:  Vibha Bhatnagar; Robert M Kaplan
Journal:  Am Fam Physician       Date:  2005-05-15       Impact factor: 3.292

5.  Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis.

Authors:  Christopher J D Wallis; Sender Herschorn; Refik Saskin; Jiandong Su; Laurence H Klotz; Michelle Chang; Girish S Kulkarni; Yuna Lee; Ronald T Kodama; Steven A Narod; Robert K Nam
Journal:  Urology       Date:  2015-03       Impact factor: 2.649

6.  The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial.

Authors:  Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Johan Stranne; Jonas Hugosson
Journal:  Eur J Cancer       Date:  2010-11-17       Impact factor: 9.162

7.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Authors:  Laurence Klotz; Danny Vesprini; Perakaa Sethukavalan; Vibhuti Jethava; Liying Zhang; Suneil Jain; Toshihiro Yamamoto; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

8.  Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.

Authors:  J Athene Lane; Jenny L Donovan; Michael Davis; Eleanor Walsh; Daniel Dedman; Liz Down; Emma L Turner; Malcolm D Mason; Chris Metcalfe; Tim J Peters; Richard M Martin; David E Neal; Freddie C Hamdy
Journal:  Lancet Oncol       Date:  2014-08-19       Impact factor: 41.316

9.  A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival.

Authors:  C Parker; D Muston; J Melia; S Moss; D Dearnaley
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640
  9 in total
  1 in total

1.  [Clarification regarding criticism on PREFERE].

Authors:  M Stöckle
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.